Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study

NCT01420237 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 367

Last updated 2025-01-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the success rate of cementless primary hip replacement with the Restoration® ADM X3® Acetabular System as compared to other primary hip systems in the literature, through absence of femoral head dislocation at 10 years postoperative.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

Restoration ADM X3 Device

Restoration ADM X3 Device in total hip replacement.

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Anthony Hedley, M.D. · Arizona Institute for Bone & Joint Disorders

  • Kipling Sharpe, M.D. · OrthoArizona

  • Craig J. Della Valle, M.D. · Rush University Medical Center

  • Geoffrey Westrich, M.D. · Hospital for Special Surgery, New York

  • Joseph Nessler, M.D. · St. Cloud Orthopedic Associates

  • Brian C de Beaubien, M.D. · Covenant Medical Center

  • Christoph Lohmann, MD · Universitatsklinikum Madgeburg A.o.R.

  • Paul Kim, MD · The Ottawa Hospital

  • Amit Atrey, MD · Unity Health Toronto

  • Brett Greenky, MD · Syracuse Orthopedic Specialists

  • Ajay Aggarwal, MD · Missouri Orthopaedic Institute

  • Edward Petrow, DO · Tucson Orthopaedic Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2023-11-09
Completion
2023-11-09

Countries

  • United States
  • Canada
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01420237 on ClinicalTrials.gov